This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2007 Nov;21(11):2368-70.

doi: 10.1038/sj.leu.2404873. Epub 2007 Jul 26.

PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma

J Abubaker, P P Bavi, S Al-Harbi, A K Siraj, F Al-Dayel, S Uddin, K Al-Kuraya

PMID: 17657213
DOI: 10.1038/sj.leu.2404873

PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma

J Abubaker et al. Leukemia. 2007 Nov.

. 2007 Nov;21(11):2368-70.

doi: 10.1038/sj.leu.2404873. Epub 2007 Jul 26.

Authors

J Abubaker, P P Bavi, S Al-Harbi, A K Siraj, F Al-Dayel, S Uddin, K Al-Kuraya

PMID: 17657213
DOI: 10.1038/sj.leu.2404873

No abstract available

PubMed Disclaimer

Similar articles

PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer.
Pérez-Tenorio G, Alkhori L, Olsson B, Waltersson MA, Nordenskjöld B, Rutqvist LE, Skoog L, Stål O. Pérez-Tenorio G, et al. Clin Cancer Res. 2007 Jun 15;13(12):3577-84. doi: 10.1158/1078-0432.CCR-06-1609. Clin Cancer Res. 2007. PMID: 17575221
PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.
Velasco A, Bussaglia E, Pallares J, Dolcet X, Llobet D, Encinas M, Llecha N, Palacios J, Prat J, Matias-Guiu X. Velasco A, et al. Hum Pathol. 2006 Nov;37(11):1465-72. doi: 10.1016/j.humpath.2006.05.007. Epub 2006 Jul 26. Hum Pathol. 2006. PMID: 16949921
PIK3CA and PTEN gene and exon mutation-specific clinicopathologic and molecular associations in colorectal cancer.
Day FL, Jorissen RN, Lipton L, Mouradov D, Sakthianandeswaren A, Christie M, Li S, Tsui C, Tie J, Desai J, Xu ZZ, Molloy P, Whitehall V, Leggett BA, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Busam D, Zhao Q, Strausberg RL, Gibbs P, Sieber OM. Day FL, et al. Clin Cancer Res. 2013 Jun 15;19(12):3285-96. doi: 10.1158/1078-0432.CCR-12-3614. Epub 2013 Apr 30. Clin Cancer Res. 2013. PMID: 23633456
High frequency of coexistent mutations of PIK3CA and PTEN genes in endometrial carcinoma.
Oda K, Stokoe D, Taketani Y, McCormick F. Oda K, et al. Cancer Res. 2005 Dec 1;65(23):10669-73. doi: 10.1158/0008-5472.CAN-05-2620. Cancer Res. 2005. PMID: 16322209
PIK3CA alterations in primary (de novo) and secondary glioblastomas.
Kita D, Yonekawa Y, Weller M, Ohgaki H. Kita D, et al. Acta Neuropathol. 2007 Mar;113(3):295-302. doi: 10.1007/s00401-006-0186-1. Epub 2007 Jan 18. Acta Neuropathol. 2007. PMID: 17235514

See all similar articles

Cited by

Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
Miletic AV, Anzelon-Mills AN, Mills DM, Omori SA, Pedersen IM, Shin DM, Ravetch JV, Bolland S, Morse HC 3rd, Rickert RC. Miletic AV, et al. J Exp Med. 2010 Oct 25;207(11):2407-20. doi: 10.1084/jem.20091962. Epub 2010 Oct 18. J Exp Med. 2010. PMID: 20956547 Free PMC article.
Research progress on the mechanism of common inflammatory pathways in the pathogenesis and development of lymphoma.
Shi A, Yun F, Shi L, Liu X, Jia Y. Shi A, et al. Ann Med. 2024 Dec;56(1):2329130. doi: 10.1080/07853890.2024.2329130. Epub 2024 Mar 15. Ann Med. 2024. PMID: 38489405 Free PMC article. Review.
Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies.
Sun R, Wang J, Young KH. Sun R, et al. Crit Rev Oncog. 2017;22(5-6):527-557. doi: 10.1615/CritRevOncog.2017020816. Crit Rev Oncog. 2017. PMID: 29604930 Free PMC article. Review.
AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.
Wang J, Xu-Monette ZY, Jabbar KJ, Shen Q, Manyam GC, Tzankov A, Visco C, Wang J, Montes-Moreno S, Dybkær K, Tam W, Bhagat G, Hsi ED, van Krieken JH, Ponzoni M, Ferreri AJM, Wang S, Møller MB, Piris MA, Medeiros LJ, Li Y, Pham LV, Young KH. Wang J, et al. Am J Pathol. 2017 Aug;187(8):1700-1716. doi: 10.1016/j.ajpath.2017.04.009. Epub 2017 Jun 13. Am J Pathol. 2017. PMID: 28627414 Free PMC article.
Knock in of the AKT1 E17K mutation in human breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.
Lauring J, Cosgrove DP, Fontana S, Gustin JP, Konishi H, Abukhdeir AM, Garay JP, Mohseni M, Wang GM, Higgins MJ, Gorkin D, Reis M, Vogelstein B, Polyak K, Cowherd M, Buckhaults PJ, Park BH. Lauring J, et al. Oncogene. 2010 Apr 22;29(16):2337-45. doi: 10.1038/onc.2009.516. Epub 2010 Jan 25. Oncogene. 2010. PMID: 20101210 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program
Miscellaneous
- NCI CPTAC Assay Portal